EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
1.5.1.28 | NADH | - |
Arthrobacter sp. |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.5.1.28 | 2.17 | - |
(S)-norvaline | pyruvate and NADH as cosubstrates | Arthrobacter sp. | |
1.5.1.28 | 2.9 | - |
L-Leu | pyruvate and NADH as cosubstrates | Arthrobacter sp. | |
1.5.1.28 | 3 | - |
L-Val | pyruvate and NADH as cosubstrates | Arthrobacter sp. | |
1.5.1.28 | 3.19 | - |
beta-chloro-(S)-alanine | pyruvate and NADH as cosubstrates | Arthrobacter sp. | |
1.5.1.28 | 3.72 | - |
(S)-norleucine | pyruvate and NADH as cosubstrates | Arthrobacter sp. | |
1.5.1.28 | 5.1 | - |
L-Ala | pyruvate and NADH as cosubstrates | Arthrobacter sp. | |
1.5.1.28 | 5.94 | - |
O-acetyl-(S)-Ser | pyruvate and NADH as cosubstrates | Arthrobacter sp. | |
1.5.1.28 | 8.7 | - |
L-Phe | pyruvate and NADH as cosubstrates | Arthrobacter sp. | |
1.5.1.28 | 8.7 | - |
O-phospho-(S)-Ser | pyruvate and NADH as cosubstrates | Arthrobacter sp. | |
1.5.1.28 | 11.9 | - |
(R,S)-2,3-diaminopropionic acid | pyruvate and NADH as cosubstrates | Arthrobacter sp. | |
1.5.1.28 | 20 | - |
(S)-2-aminobutanoate | pyruvate and NADH as cosubstrates | Arthrobacter sp. | |
1.5.1.28 | 28.3 | - |
L-phenylglycine | pyruvate and NADH as cosubstrates | Arthrobacter sp. |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.5.1.28 | Arthrobacter sp. | - |
- |
- |
1.5.1.28 | Arthrobacter sp. 1C | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.5.1.28 | (R,S)-2,3-Diaminopropionic acid + pyruvate + NADH | 9.67% of the activity with S: (S)-norvaline | Arthrobacter sp. | ? | - |
? | |
1.5.1.28 | (R,S)-3-Aminobutanoate + pyruvate + NADH | 0.68% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-(R,S)-3-aminobutanoate + NAD+ | - |
? | |
1.5.1.28 | (S)-2-aminobutyric acid + pyruvate + NADH | 83.7% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(carboxy)ethyl]-(S)-2-aminobutyric acid + NAD+ | - |
? | |
1.5.1.28 | (S)-2-aminobutyric acid + pyruvate + NADH | 83.7% of the activity with (S)-norvaline | Arthrobacter sp. 1C | N-[1-(R)-(carboxy)ethyl]-(S)-2-aminobutyric acid + NAD+ | - |
? | |
1.5.1.28 | (S)-Norleucine + pyruvate + NADH | 72.5% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-norleucine + NAD+ | - |
? | |
1.5.1.28 | (S)-Norleucine + pyruvate + NADH | 72.5% of the activity with (S)-norvaline | Arthrobacter sp. 1C | N-[1-(R)-(Carboxy)ethyl]-norleucine + NAD+ | - |
? | |
1.5.1.28 | (S)-Norvaline + pyruvate + NADH | - |
Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-(S)-norvaline + NAD+ | - |
? | |
1.5.1.28 | (S)-Norvaline + pyruvate + NADH | - |
Arthrobacter sp. 1C | N-[1-(R)-(Carboxy)ethyl]-(S)-norvaline + NAD+ | - |
? | |
1.5.1.28 | (S)-Phenylalaninol + pyruvate + NADH | 0.63% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-(S)-phenylalaninol + NAD+ | - |
? | |
1.5.1.28 | (S)-Phenylglycine + pyruvate + NADH | 4.4% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-(S)-phenylglycine + NAD+ | - |
? | |
1.5.1.28 | beta-Chloro-(S)-Ala + pyruvate + NADH | 53.1% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-(S)-beta-chloroalanine + NAD+ | - |
? | |
1.5.1.28 | beta-Chloro-(S)-Ala + pyruvate + NADH | 53.1% of the activity with (S)-norvaline | Arthrobacter sp. 1C | N-[1-(R)-(Carboxy)ethyl]-(S)-beta-chloroalanine + NAD+ | - |
? | |
1.5.1.28 | L-Ala + pyruvate + NADH | 16.0% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-(S)-Ala + NAD+ | - |
? | |
1.5.1.28 | L-Ile + pyruvate + NADH | 22.3% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-(S)-Ile + NAD+ | - |
? | |
1.5.1.28 | L-Leu + pyruvate + NADH | 21.2% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-(S)-Leu + NAD+ | - |
? | |
1.5.1.28 | L-Met + pyruvate + NADH | 23.9% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-(S)-Met + NAD+ | - |
? | |
1.5.1.28 | L-Phe + pyruvate + NADH | 21.7% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-(S)-Phe + NAD+ | - |
? | |
1.5.1.28 | L-Val + pyruvate + NADH | 21.9% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-(S)-Val + NAD+ | - |
? | |
1.5.1.28 | O-Acetyl-(S)-Ser + pyruvate + NADH | 35.8% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-(S)-O-acetyl-Ser + NAD+ | - |
? | |
1.5.1.28 | O-Acetyl-(S)-Ser + pyruvate + NADH | 35.8% of the activity with (S)-norvaline | Arthrobacter sp. 1C | N-[1-(R)-(Carboxy)ethyl]-(S)-O-acetyl-Ser + NAD+ | - |
? | |
1.5.1.28 | O-phospho-(S)-Ser + pyruvate + NADH + H+ | - |
Arthrobacter sp. | N-[1-(R)-(carboxy)ethyl]-(S)-O-phospho-Ser + NAD+ | - |
r | |
1.5.1.28 | p-Phospho-(S)-Tyr + pyruvate + NADH | 0.64% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-(R,S)-p-phospho-(S)-Tyr + NAD+ | - |
? | |
1.5.1.28 | phospho-(S)-Ser + pyruvate + NADH | 15.8% of the activity with (S)-norvaline | Arthrobacter sp. | N-[1-(R)-(Carboxy)ethyl]-phospho-Ser + NAD+ | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.5.1.28 | N-[1-(R)-(Carboxy)ethyl]-(S)-norvaline: NAD+ oxidoreductase (L-norvaline forming) | - |
Arthrobacter sp. |
1.5.1.28 | ODH | - |
Arthrobacter sp. |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.5.1.28 | NADH | - |
Arthrobacter sp. |